首页> 外文OA文献 >Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished
【2h】

Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished

机译:通过使用具有天然嗜性的单链抗体靶向腺病毒载体,高效,选择性地将基因转移到原发性人脑肿瘤中

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The application of adenoviral vectors in cancer gene therapy is hampered by low receptor expression on tumor cells and high receptor expression on normal epithelial cells. Targeting adenoviral vectors toward tumor cells may improve cancer gene therapy procedures by providing augmented tumor transduction and decreased toxicity to normal tissues. Targeting requires both the complete abolition of native tropism and the addition of a new specific binding ligand onto the viral capsid. Here we accomplished this by using doubly ablated adenoviral vectors, lacking coxsackievirus-adenovirus receptor and alpha(v), integrin binding capacities, together with bispecific single-chain antibodies targeted toward human epidermal growth factor receptor (EGFR) or the epithelial cell adhesion molecule. These vectors efficiently and selectively targeted both alternative receptors on the surface of human cancer cells. Targeted doubly ablated adenoviral vectors were also very efficient and specific with primary human tumor specimens. With primary glioma cell cultures, EGFR targeting augmented the median gene transfer efficiency of doubly ablated adenoviral vectors 123-fold. Moreover, EGFR-targeted doubly ablated vectors were selective for human brain tumors versus the surrounding normal brain tissue. They transduced organotypic glioma and meningioma spheroids with efficiencies similar to those of native adenoviral vectors, while exhibiting greater-than-10-fold-reduced background levels on normal brain explants from the same patients. As a result, EGFR-targeted doubly ablated adenoviral vectors had a 5- to 38-fold-improved tumor-to-normal brain targeting index compared to native vectors. Hence, single-chain targeted doubly ablated adenoviral vectors are promising tools for cancer gene therapy. They should provide an improved therapeutic index with efficient tumor transduction and effective protection of normal tissue.
机译:腺病毒载体在癌症基因治疗中的应用受到肿瘤细胞低受体表达和正常上皮细胞高受体表达的阻碍。通过提供增强的肿瘤转导和对正常组织的毒性降低,将腺病毒载体靶向肿瘤细胞可以改善癌症基因治疗程序。靶向既需要完全消除天然嗜性,又需要在病毒衣壳上添加新的特异性结合配体。在这里,我们通过使用双重消融的腺病毒载体,缺乏柯萨奇病毒-腺病毒受体和alpha(v),整联蛋白结合能力,以及针对人表皮生长因子受体(EGFR)或上皮细胞粘附分子的双特异性单链抗体,实现了这一目标。这些载体有效和选择性地靶向人类癌细胞表面上的两种替代受体。靶向双消融腺病毒载体对原发性人类肿瘤标本也非常有效且具有特异性。在原发性神经胶质瘤细胞培养中,EGFR靶向可将双消融腺病毒载体的中位基因转移效率提高123倍。而且,靶向EGFR的双消融载体对人脑肿瘤相对于周围的正常脑组织具有选择性。他们转导了器官型神经胶质瘤和脑膜瘤的球体,其效率与天然腺病毒载体相似,同时在相同患者的正常脑外植体上,其背景水平降低了十倍以上。结果,与天然载体相比,EGFR靶向的双消融腺病毒载体的肿瘤对正常脑靶向指数提高了5到38倍。因此,单链靶向双消融腺病毒载体是用于癌症基因治疗的有前途的工具。它们应提供具有有效的肿瘤转导和对正常组织的有效保护的改善的治疗指数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号